tiprankstipranks
Trending News
More News >
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Hong Kong Market

Simcere Pharmaceutical Group Limited (2096) Income Statement

Compare
5 Followers

Simcere Pharmaceutical Group Limited Income Statement

Last quarter (Q2 2025), Simcere Pharmaceutical Group Limited's total revenue was ¥3.58B, an increase of 6.08% from the same quarter last year. In Q2, Simcere Pharmaceutical Group Limited's net income was ¥603.61M. See Simcere Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 6.64B¥ 6.61B¥ 6.32B¥ 5.00B¥ 4.51B
Gross Profit
¥ 5.32B¥ 4.98B¥ 5.00B¥ 3.92B¥ 3.61B
Operating Expenses
¥ 4.48B¥ 4.27B¥ 4.14B¥ 2.47B¥ 2.68B
Depreciation and Amortization
¥ 214.29M¥ 309.59M¥ 209.04M¥ 189.12M¥ 158.63M
EBITDA
¥ 1.35B¥ 1.08B¥ 815.38M¥ 422.45M¥ 758.55M
Operating Income
¥ 848.05M¥ 711.80M¥ 862.50M¥ 1.45B¥ 926.84M
Other Income/Expenses
¥ -28.17M¥ 28.24M¥ 25.65M¥ -46.75M¥ -121.75M
Pretax Income
¥ 819.88M¥ 740.04M¥ 888.15M¥ 1.40B¥ 805.09M
Net Income
¥ 733.16M¥ 714.76M¥ 930.87M¥ 1.51B¥ 669.53M
Per Share Metrics
Basic EPS
¥ 0.29¥ 0.27¥ 0.36¥ 0.58¥ 0.26
Diluted EPS
¥ 0.29¥ 0.27¥ 0.36¥ 0.58¥ 0.26
Weighted Average Shares Outstanding
2.53B 2.65B 2.61B 2.61B 2.61B
Weighted Average Shares Outstanding (Diluted)
2.52B 2.61B 2.62B 2.61B 2.61B
Currency in CNY

Simcere Pharmaceutical Group Limited Earnings and Revenue History